BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

573 related articles for article (PubMed ID: 30289322)

  • 1. Association analysis of genetic polymorphisms and expression levels of selected genes involved in extracellular matrix turnover and angiogenesis with the risk of age-related macular degeneration.
    Oszajca K; Szemraj M; Szemraj J; Jurowski P
    Ophthalmic Genet; 2018 Dec; 39(6):684-698. PubMed ID: 30289322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Matrix Metalloproteinases Polymorphisms in Age-Related Macular Degeneration.
    Liutkeviciene R; Lesauskaite V; Sinkunaite-Marsalkiene G; Zaliuniene D; Zaliaduonyte-Peksiene D; Mizariene V; Gustiene O; Jasinskas V; Jariene G; Tamosiunas A
    Ophthalmic Genet; 2015 Jun; 36(2):149-55. PubMed ID: 24079541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia activates matrix metalloproteinase expression and the VEGF system in monkey choroid-retinal endothelial cells: Involvement of cytosolic phospholipase A2 activity.
    Ottino P; Finley J; Rojo E; Ottlecz A; Lambrou GN; Bazan HE; Bazan NG
    Mol Vis; 2004 May; 10():341-50. PubMed ID: 15162095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of MMP2 (-1306C>T) and TIMP2 (-418 G>C) promoter variants in age-related macular degeneration.
    Ortak H; Demir S; Ateş Ö; Benli İ; Söğüt E; Sahin M
    Ophthalmic Genet; 2013 Dec; 34(4):217-22. PubMed ID: 23536957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher risk of matrix metalloproteinase (MMP-2, 7, 9) and tissue inhibitor of metalloproteinase (TIMP-2) genetic variants to gallbladder cancer.
    Sharma KL; Misra S; Kumar A; Mittal B
    Liver Int; 2012 Sep; 32(8):1278-86. PubMed ID: 22621753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autophagy Genes for Wet Age-Related Macular Degeneration in a Finnish Case-Control Study.
    Paterno JJ; Koskela A; Hyttinen JMT; Vattulainen E; Synowiec E; Tuuminen R; Watala C; Blasiak J; Kaarniranta K
    Genes (Basel); 2020 Nov; 11(11):. PubMed ID: 33172148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The selected genetic polymorphisms of metalloproteinases MMP2, 7, 9 and MMP inhibitor TIMP2 in sarcoidosis.
    Piotrowski WJ; Górski P; Pietras T; Fendler W; Szemraj J
    Med Sci Monit; 2011 Oct; 17(10):CR598-607. PubMed ID: 21959615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in regulators of the extracellular matrix in non-Hodgkin lymphomas.
    Negaard HF; Svennevig K; Kolset SO; Iversen N; Lothe IM; Østenstad B; Sandset PM; Iversen PO
    Leuk Lymphoma; 2009 Jun; 50(6):998-1004. PubMed ID: 19373600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of MMP-2, MMP-7, MMP-9 and TIMP-2 in the development of recurrent depressive disorder.
    Bobińska K; Szemraj J; Czarny P; Gałecki P
    J Affect Disord; 2016 Nov; 205():119-129. PubMed ID: 27434116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of polymorphism of matrix metalloproteinase-2 and metalloproteinase tissue inhibitor-2 promoters in breast cancer in Tunisia: case-control study.
    Ben Néjima D; Ben Zarkouna Y; Gammoudi A; Manai M; Boussen H
    Tumour Biol; 2015 May; 36(5):3815-22. PubMed ID: 25656607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between vascular endothelial growth factor gene polymorphisms and age-related macular degeneration in a Polish population.
    Janik-Papis K; Zaras M; Krzyzanowska A; Wozniak K; Blasiak J; Szaflik J; Szaflik JP
    Exp Mol Pathol; 2009 Dec; 87(3):234-8. PubMed ID: 19761764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinase-2 promoter and tissue inhibitor of metalloproteinase-2 gene polymorphisms in non-Hodgkin's lymphoma.
    Diao LP; Ma H; Wei GC; Li T; Liu HS; Liu LH; Wu LL; Zhao GM; Gao YH
    Int J Cancer; 2012 Sep; 131(5):1095-103. PubMed ID: 22020421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of exudative age-related macular degeneration with matrix metalloproteinases-2 (-1306 C/T) rs243865 gene polymorphism.
    Liutkeviciene R; Vilkeviciute A; Borisovaite D; Miniauskiene G
    Indian J Ophthalmol; 2018 Apr; 66(4):551-557. PubMed ID: 29582818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of matrix metalloproteinase-2 and tissue inhibitor matrix metalloproteinase-2 gene polymorphisms and immunohistochemical expressions in intracranial meningiomas.
    Coven İ; Ozer O; Ozen O; Şahin Fİ; Altinors N
    J Neurosurg; 2014 Dec; 121(6):1478-82. PubMed ID: 25259564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association of vascular endothelial growth factor, metalloproteinases and their tissue inhibitors with cardiovascular risk factors in the metabolic syndrome.
    Erman H; Gelisgen R; Cengiz M; Tabak O; Erdenen F; Uzun H
    Eur Rev Med Pharmacol Sci; 2016; 20(6):1015-22. PubMed ID: 27049251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Relationship Between MMP-2 -1306C>T and MMP-9 -1562C>T Polymorphisms and the Risk and Prognosis of T-Cell Acute Lymphoblastic Leukemia in a Chinese Population: A Case-Control Study.
    Lin CM; Zeng YL; Xiao M; Mei XQ; Shen LY; Guo MX; Lin ZY; Liu QF; Yang T
    Cell Physiol Biochem; 2017; 42(4):1458-1468. PubMed ID: 28719899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor expression correlates with matrix metalloproteinases MT1-MMP, MMP-2 and MMP-9 in human glioblastomas.
    Munaut C; Noël A; Hougrand O; Foidart JM; Boniver J; Deprez M
    Int J Cancer; 2003 Oct; 106(6):848-55. PubMed ID: 12918061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on the association of SNPs of MMP-2 and TIMP-2 genes with the risk of endometriosis and adenomyosis].
    Zhao XW; Li Y; Wang N; Zhao J; Li XL; Liu Q; Jia JH; Yang ZF; Kang S
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Jun; 25(3):280-3. PubMed ID: 18543216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Significance of Matrix Metalloproteinases in Blood Plasma of Patients with Gastric Cancer.
    Kushlinskii NE; Gershtein ES; Ivannikov AA; Davydov MM; Chang VL; Ognerubov NA; Stilidi IS
    Bull Exp Biol Med; 2019 Jan; 166(3):373-376. PubMed ID: 30627896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms in vascular endothelial growth factor receptor 2 are associated with better response rates to ranibizumab treatment in age-related macular degeneration.
    Hermann MM; van Asten F; Muether PS; Smailhodzic D; Lichtner P; Hoyng CB; Kirchhof B; Grefkes C; den Hollander AI; Fauser S
    Ophthalmology; 2014 Apr; 121(4):905-10. PubMed ID: 24365177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.